Rickettsial Genesis to Sarcoidosis in Denmark
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00326534|
Recruitment Status : Completed
First Posted : May 17, 2006
Last Update Posted : March 9, 2009
One study has suggested a connection between an infection with Rickettsia species and sarcoidosis finding molecular evidence of rickettsial deoxyribonucleic acid (DNA) in two patients. Another study found no antibodies in twenty Swedish patients with sarcoidosis.
This study will further enhance the subject by three different approaches in Danish patients.
The purpose of this study is to find serological and molecular evidence of an infection with Rickettsia species in Danish patients with sarcoidosis.
|Condition or disease|
|Sarcoidosis Rickettsia Infections|
The study has three approaches to the subject:
- A serological survey of rickettsial immunoglobin G (IgG)-antibodies in 50 patients with sarcoidosis compared to 50 blood donors without sarcoidosis.
- An archival study using pre-existing lymph node biopsies, where immunohistochemical analysis, fluorescent in situ hybridization, and polymerase chain reaction will be applied to samples from 50 patients with sarcoidosis and compared to 50 patients without sarcoidosis and 10 patients with tuberculosis.
- A prospective study using bronchoscopically obtained samples from 20 patients with sarcoidosis, compared to 20 patients without sarcoidosis. The study applies the same techniques as the second study, but enhancing the information from the patients.
|Study Type :||Observational|
|Actual Enrollment :||36 participants|
|Observational Model:||Case Control|
|Official Title:||Rickettsial Genesis to Sarcoidosis in Denmark|
|Study Start Date :||September 2006|
|Actual Primary Completion Date :||January 2009|
|Actual Study Completion Date :||March 2009|
Patients without sarcoidosis, but requiring a fiberoptic bronchoscopy
Patients with newly diagnosed sarcoidosis
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00326534
|Copenhagen S, Denmark, 2300|
|Principal Investigator:||Claus B Svendsen, MD||Statens Serum Institut|
|Study Chair:||Nils Milman, MD||Rigshospitalet, Denmark|
|Study Chair:||Karen A Krogfelt, PhD||Statens Serum Institut|